SL

Saquib Latif

Active Director Director DIN 08219649
DIN 08219649 First appointment Sep 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Saquib Latif

Data last updated:

Saquib Latif is a Director at Peerage Pharma Private Limited (since 2018). The company operates in Pharma. Peerage Pharma Private Limited reported revenue of ₹3.21 Cr (FY 2024).

DIN 08219649
Primary Designation Director
Industry Pharma
First Appointment 08 Sep 2018
Oldest Company Age 21 yrs
Largest company Peerage Pharma Private Limited · ₹3.21 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Peerage Pharma Private Limited U24232CH2005PTC027847
Director08 Sep 20182005₹3.21 Cr (FY 2024)Active

Board colleagues of Saquib Latif

Directorship timeline

Open interactive timeline →
Peerage Pharma Private Limited
Premium access

Shareholding and investment profile for Saquib Latif

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saquib Latif

Saquib Latif currently holds 1 directorship: Peerage Pharma Private Limited (Director, since 08 Sep 2018, revenue ₹3.21 Cr (FY 2024)).

Saquib Latif was first appointed on 08 Sep 2018 as Director at Peerage Pharma Private Limited.

The current boards of Saquib Latif's companies include Aqib Latif Wani (Peerage Pharma Private Limited), Latif Ahmad Wani (Peerage Pharma Private Limited), Maimona Akhtar (Peerage Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available